| Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers R Hamam, D Hamam, KA Alsaleh, M Kassem, W Zaher, M Alfayez, ... Cell death & disease 8 (9), e3045-e3045, 2017 | 346 | 2017 |
| microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection R Hamam, AM Ali, KA Alsaleh, M Kassem, M Alfayez, A Aldahmash, ... Scientific reports 6 (1), 25997, 2016 | 157 | 2016 |
| The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials K Alsaleh, GS Alotaibi, HS Almodaimegh, AA Aleem, CT Kouroukis The Journal of arthroplasty 28 (9), 1463-1472, 2013 | 99 | 2013 |
| Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation KA Al-Anazi, AM Al-Jasser, K Alsaleh Frontiers in oncology 4, 231, 2014 | 68 | 2014 |
| Role of Pemetrexed in Sdvanced Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Controlled Trials, with Histology Subgroup Analysis K Al-Saleh, C Quinton, PM Ellis Current Oncology 19 (1), 9-15, 2012 | 66 | 2012 |
| Predictive and prognostic significance of CD8+ tumor‑infiltrating lymphocytes in patients with luminal B/HER 2 negative breast cancer treated with neoadjuvant chemotherapy K Al‑Saleh, A El‑Aziz, A Ali, W Abozeed, A El‑Warith, A Ibraheem, J Ansari, ... Oncology letters 14 (1), 337-344, 2017 | 53 | 2017 |
| A meta-analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer A Abdulla, WM Davis, N Ratnaweera, E Szefer, BB Scott, AYY Lee Thrombosis and haemostasis 120 (04), 702-713, 2020 | 52 | 2020 |
| Review on breast cancer in the Kingdom of Saudi Arabia A Al Diab, S Qureshi, KA Al Saleh, FH Al Qahtani, A Aleem, M Algamdi Middle-East J Sci Res 14 (4), 532-43, 2013 | 49 | 2013 |
| Multitargeted anti-angiogenic agents and NSCLC: clinical update and future directions PM Ellis, K Al-Saleh Critical reviews in oncology/hematology 84 (1), 47-58, 2012 | 48 | 2012 |
| Delayed‐onset HIT caused by low‐molecular‐weight heparin manifesting during fondaparinux prophylaxis KA Alsaleh, SMA Al‐Nasser, SM Bates, A Patel, TE Warkentin, DM Arnold American journal of hematology 83 (11), 876-878, 2008 | 48 | 2008 |
| Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention C Wu, GS Alotaibi, K Alsaleh, LA Linkins, MS McMurtry Thrombosis research 135 (2), 243-248, 2015 | 46 | 2015 |
| Triple negative breast cancer: A tale of two decades A M Ali, J AK Ansari, N M Abd El-Aziz, W N Abozeed, A M Abdel Warith, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 43 | 2017 |
| Mammographic breast density: predictive value for pathological response to neoadjuvant chemotherapy in breast cancer patients S Elsamany, A Alzahrani, WN Abozeed, A Rasmy, MU Farooq, ... The Breast 24 (5), 576-581, 2015 | 34 | 2015 |
| MicroRNA expression profiling on paired primary and lymph node metastatic breast cancer revealed distinct microRNA profile associated with LNM R Elango, KA Alsaleh, R Vishnubalaji, M Manikandan, AM Ali, ... Frontiers in oncology 10, 756, 2020 | 33 | 2020 |
| Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review C Wu, GS Alotaibi, K Alsaleh, MS McMurtry Thrombosis research 134 (3), 627-632, 2014 | 33 | 2014 |
| Validity and feasibility of the Arabic version of distress thermometer for Saudi cancer patients FD Alosaimi, N Abdel-Aziz, K Alsaleh, R AlSheikh, R AlSheikh, ... PLoS One 13 (11), e0207364, 2018 | 32 | 2018 |
| Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis. G Alotaibi, K Alsaleh, C Wu, MS McMurtry International angiology: a journal of the International Union of Angiology …, 2014 | 32 | 2014 |
| Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages MH Abdulla, MA Valli-Mohammed, K Al-Khayal, A Al Shkieh, A Zubaidi, ... Oncology reports 37 (6), 3175-3180, 2017 | 30 | 2017 |
| The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism: outpatient versus inpatient management FM Al-Hameed, HM Al-Dorzi, AM Al-Momen, FH Algahtani, HA Al-Zahrani, ... Saudi medical journal 36 (8), 1004, 2015 | 24 | 2015 |
| Routine administration of standardized questionnaires that assess aspects of patients’ quality of life in medical oncology clinics: a systematic review K Alsaleh Journal of the Egyptian National Cancer Institute 25 (2), 63-70, 2013 | 23 | 2013 |
